These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 33194391)

  • 1. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues.
    Atay S
    PeerJ; 2020; 8():e10141. PubMed ID: 33194391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets.
    Ma Y; Pu Y; Peng L; Luo X; Xu J; Peng Y; Tang X
    Oncol Lett; 2019 Dec; 18(6):6741-6751. PubMed ID: 31807183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
    Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
    Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression.
    Pan Z; Li L; Fang Q; Zhang Y; Hu X; Qian Y; Huang P
    Cancer Cell Int; 2018; 18():214. PubMed ID: 30598639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma
    Lei X; Chen G; Li J; Wen W; Gong J; Fu J
    PeerJ; 2021; 9():e12141. PubMed ID: 34567847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.
    Lu Y; Li C; Chen H; Zhong W
    Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway.
    Yao LC; Jiang XH; Yan SS; Wang W; Wu L; Zhai LL; Xiang F; Ji T; Ye L; Tang ZG
    Oncol Lett; 2021 Apr; 21(4):326. PubMed ID: 33692858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis.
    Tang Y; Zhang Z; Tang Y; Chen X; Zhou J
    Oncol Lett; 2018 Aug; 16(2):2453-2461. PubMed ID: 30013637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
    Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of molecular pathways in pancreatic ductal adenocarcinomas with a bioinformatics approach.
    Wang Y; Li Y
    Asian Pac J Cancer Prev; 2015; 16(6):2561-7. PubMed ID: 25824797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
    Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
    Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.
    Li H; Wang X; Fang Y; Huo Z; Lu X; Zhan X; Deng X; Peng C; Shen B
    Oncotarget; 2017 Aug; 8(32):52571-52583. PubMed ID: 28881752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes.
    Zheng B; Peng J; Mollayup A; Bakri A; Guo L; Zheng J; Xu H
    Mol Med Rep; 2018 Jan; 17(1):216-224. PubMed ID: 29115420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression Characteristics of Tumor and Adjacent Non-Tumor Tissues of Pancreatic Ductal Adenocarcinoma (PDAC) In-Silico.
    Güven E
    Iran J Biotechnol; 2022 Jan; 20(1):e3092. PubMed ID: 35891953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate agents for pancreatic ductal adenocarcinoma identified by a sub-pathway based method.
    Lin Y; Jin Y; Lin LJ; Cao Y; Zhang Y; Chen SF; Zheng CQ
    Gene; 2014 May; 540(2):232-7. PubMed ID: 24561286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
    Tian X; Wang N
    Oncol Lett; 2020 Apr; 19(4):3307-3315. PubMed ID: 32218868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.
    Kordshouli SO; Tahmasebi A; Moghadam A; Ramezani A; Niazi A
    PLoS One; 2024; 19(2):e0289561. PubMed ID: 38324544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.